More ImpediMed Limited news
ImpediMed LimitedASX: IPD

ImpediMed Announces Appointment of Managing Director and CEO

Nov 28, 2022 at 9:51 PM EST · Issued by ImpediMed Limited

Filed with ASX · Nov 28, 2022 at 9:51 PM EST · 5 pages · English

On 6ix: 6ix.com/news/impedimed-announces-appointment-of-managing-director-and-ceo

Watch ImpediMed's latest callImpediMed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29↗

ImpediMed Limited on 6ix

Earlier from ImpediMed

  • ImpediMed Announces Management ReorganisationNov 21, 2022
  • AstraZeneca Further Extends Clinical Trial ContractNov 9, 2022
  • Appendix 4C & Quarterly Activities Report - Sep-22 QtrOct 19, 2022
  • New Corporate Oncology Account with GenesisCareOct 3, 2022
  • 2022 Annual Report & Annual General Meeting DateAug 28, 2022

Later from ImpediMed

  • New Version of NCCN Guidelines for Breast CancerJan 29, 2023
  • Appendix 4C & Quarterly Activities Report - Dec-22 QtrJan 29, 2023
  • S&P DJI Announces March 2023 Quarterly RebalanceMar 3, 2023
  • NCCN Guidelines Now Recommend Bioimpedance SpectroscopyMar 26, 2023
  • Appendix 4C & Quarterly Activities Report - Mar-23 QtrApr 16, 2023
All ImpediMed news releases↗

Follow ImpediMed into a list and get an email when it puts out news.

Follow ImpediMed
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer